Precipio Inc (PRPO)
Precipio Inc. is a healthcare biotechnology company listed on NASDAQ under the ticker PRPO. As an ordinary common stock issue, the security represents equity in the company rather than a specialized fund or structured instrument. The company focuses on cancer diagnostics in the United States, with products, reagents, and services centered on blood cancer testing. Its offerings include IV-Cell, a proprietary cell culture medium designed to support simultaneous growth of four hematopoietic cell lineages, and HemeScreen, a set of genetic diagnostic panels. Precipio also provides biomarker testing and clinical project services to biopharma customers. The company is based in New Haven, Connecticut.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-PRPO
|
$24.40
|
3.8% Upside
|
Fair
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
August 12, 2026
|
-45.6x
|
3.0x
|
1.6x
|
41.825 M
|
42.891 M
|
7.7%
|
78.5%
|
-8.4
|
—
|
-60.2%
|
